Term | GS = 6 | GS = 7 | ||||
---|---|---|---|---|---|---|
NGSU | GSU | P-value | NGSU | GSU | P-value | |
Case | 20 (38.5%) | 32 (61.5%) | 36 (46.2%) | 42 (53.8%) | ||
Age | 65.60 ± 5.48 | 65.94 ± 5.71 | 0.833 | 67.03 ± 7.03 | 66.43 ± 5.71 | 0.684 |
BMI | 24.27 ± 3.07 | 25.36 ± 2.91 | 0.207 | 24.82 ± 3.18 | 24.61 ± 3.17 | 0.775 |
Hypertension | 6 (30.0%) | 14 (70.0%) | 0.389 | 14 (42.4%) | 19 (57.6%) | 0.649 |
Diabetes Mellitus | 4 (33.3%) | 8 (66.7%) | 0.747 | 8 (53.3%) | 7 (46.7%) | 0.576 |
MetS | 4 (28.6%) | 10 (71.4%) | 0.524 | 10 (41.7%) | 14 (58.3%) | 0.631 |
Total-PSA (ng/ml) | 10.91 ± 7.97 | 12.71 ± 14.87 | 0.621 | 23.56 ± 27.47 | 26.16 ± 22.71 | 0.648 |
Free-PSA (ng/ml) | 1.37 ± 0.90 | 2.05 ± 3.40 | 0.424 | 1.64 ± 1.09 | 2.29 ± 2.41 | 0.172 |
PSA | 0.999 | 0.245 | ||||
PSA ≤ 4 | 2 (33.3%) | 4 (66.7%) | 0 (0.0%) | 3 (100.0%) | ||
PSA > 4 | 18 (39.1%) | 28 (60.9%) | 36 (48.0%) | 39 (52.0%) | ||
Free PSA/Total PSA ratio | 0.739 | 0.662 | ||||
≤ 18% | 13 (39.4%) | 20 (60.6%) | 27 (46.6%) | 31 (53.4%) | ||
> 18% | 4 (30.8%) | 9 (69.2%) | 3 (60.0%) | 2 (40.0%) | ||
PV (ml) | 82.07 ± 42.47 | 83.68 ± 41.95 | 0.907 | 88.77 ± 51.57 | 73.99 ± 29.62 | 0.205 |
PI-RADS | 0.185 | 0.126 | ||||
1 | 1 (50.0%) | 1 (50.0%) | 0 (0.0%) | 1 (100.0%) | ||
2 | 7 (70.0%) | 3 (30.0%) | 8 (57.1%) | 6 (42.9%) | ||
3 | 2 (22.2%) | 7 (77.8%) | 3 (30.0%) | 7 (70.0%) | ||
4 | 9 (34.6%) | 17 (65.4%) | 18 (60.0%) | 12 (40.0%) | ||
5 | 1 (20.0%) | 4 (80.0%) | 7 (30.4%) | 16 (69.6%) | ||
Number of biopsy cores | 24.10 ± 0.45 | 24.16 ± 0.52 | 0.689 | 23.33 ± 2.65 | 22.62 ± 4.20 | 0.381 |
Rate of positive cores in biopsy | 0.18 ± 0.13 | 0.21 ± 0.17 | 0.384 | 0.29 ± 0.19 | 0.38 ± 0.22 | 0.066 |
Clinical stage | 0.576 | 0.345 | ||||
T1 | 2 (66.7%) | 1 (33.3%) | 2 (66.7%) | 1 (33.3%) | ||
T2 | 16 (37.2%) | 27 (62.8%) | 30 (47.6%) | 33 (52.4%) | ||
T3 | 2 (33.3%) | 4 (66.7%) | 3 (27.3%) | 8 (72.7%) | ||
Triglyceride (mg/dL) | 1.79 ± 1.40 | 1.65 ± 1.95 | 0.791 | 1.37 ± 0.87 | 1.44 ± 0.92 | 0.773 |
HDL-C (mg/dL) | 1.13 ± 0.16 | 1.17 ± 0.40 | 0.658 | 1.08 ± 0.20 | 1.20 ± 0.28 | 0.044 |
Lymphocyte counts (× 109/L) | 1.58 ± 0.52 | 1.46 ± 0.82 | 0.563 | 1.42 ± 0.86 | 1.55 ± 0.71 | 0.441 |
Percentage of lymphocyte (%) | 26.44 ± 9.02 | 19.56 ± 13.26 | 0.031 | 20.63 ± 12.74 | 19.85 ± 12.04 | 0.783 |
Neutrophile counts (× 109/L) | 4.13 ± 1.69 | 5.80 ± 3.13 | 0.016 | 5.69 ± 3.42 | 6.84 ± 3.22 | 0.133 |
Percentage of neutrophile (%) | 64.03 ± 11.94 | 69.42 ± 18.24 | 0.204 | 71.91 ± 14.56 | 69.10 ± 17.91 | 0.454 |
NLR | 3.38 ± 3.50 | 6.84 ± 7.61 | 0.031 | 6.77 ± 8.29 | 8.46 ± 14.11 | 0.530 |
Hb (g/L) | 137.65 ± 9.70 | 130.31 ± 17.46 | 0.057 | 132.39 ± 14.64 | 128.12 ± 17.40 | 0.249 |